title: [Anti-TNF-alpha antibody treatment of patients with active ulcerative colitis].
abstract: Recently published studies have demonstrated that infliximab is effective not only in Crohn's disease, but also in ulcerative colitis. The present article reviews current treatment options for severe ulcerative colitis as well as available data on the effect of infliximab in the treatment of this disease. The article discusses the possible future role of infliximab in the treatment of ulcerative colitis.
authors.affiliation: Herlev Hospital, Medicinsk-gastroenterologisk Afdeling C. mark.ainsworth@dadlnet.dk
authors.forename: Mark A
authors.initials: MA
authors.lastname: Ainsworth
authors.forename: Jørgen
authors.initials: J
authors.lastname: Brynskov
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D016572:Cyclosporine / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000069285:Infliximab; D016896:Treatment Outcome
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D000069285:Infliximab